Scientific or therapeutic information has become such an extraordinary financial issue that it can be subject to extraordinary manipulation. The information concerning the possibility of using or not the drug which would like to find its place for Covid (the Remdesivir of Gilead) involves fluctuations in the price of Gilead which relates to several billion dollars after each scientific or authority announcement. In addition, the market for scientific publishing is considerable and generates extreme profits of around 35%. And he also has capital that is built in part with the same American fund managers as Gilead.
Read also: Coronavirus: will the epidemic disappear on its own, as Professor Raoult claims?
Beyond these financial interests which are colossal and go beyond what I had known until then, political interests mingle. Since Donald Trump decided to recommend hydroxychloroquine (I never had contact with Donald Trump or with Bolsonaro), the war against Trump has started a war
This article is for subscribers only. You still have 73% to discover.
Subscribe: € 1 the first month
cancellable at any time
Enter your emailAlready subscribed? Log in